Old Web
English
Sign In
Acemap
>
authorDetail
>
Michael D. Keppen
Michael D. Keppen
University of Arkansas
Medicine
Oncology
Chemotherapy
Internal medicine
Toxicity
4
Papers
85
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A phase II evaluation of ifosfamide and mesna in unresectable diffuse malignant mesothelioma. A Southwest Oncology Group study.
1992
Cancer
Bernard L. Zidar
Barbara Metch
Stanley P. Balcerzak
H. Irving Pierce
Liboria Militello
Michael D. Keppen
Jeffrey L. Berenberg
Show All
Source
Cite
Save
Citations (43)
Evaluation of amonafide in refractory and relapsing multiple myeloma: a Southwest Oncology Group study.
1991
Anti-Cancer Drugs
Karl H Hanson
John Crowley
Sydney E. Salmon
Michael D. Keppen
Thomas J Braun
John D. Bonnet
Show All
Source
Cite
Save
Citations (3)
Phase II study of fludarabine phosphate in multiple myeloma. A Southwest Oncology Group study.
1990
Investigational New Drugs
Eric H. Kraut
John Crowley
Michael R. Grever
Michael D. Keppen
John D. Bonnet
Henry E. Hynes
Sydney E. Salmon
Show All
Source
Cite
Save
Citations (37)
Cyclophosphamide, vincristine, cisplatin, VP-16 and radiation therapy in extensive small-cell lung cancer - A Southwest Oncology Group study
1989
Cancer Chemotherapy and Pharmacology
Carolyn Collins
Celestia S. Higano
Robert B. Livingston
Brian R. Griffin
Michael D. Keppen
Thomas P. Miller
Show All
Source
Cite
Save
Citations (2)
1